Premium
Systemic 5‐fluorouracil producing an inflammatory response in porokeratosis
Author(s) -
Nahm WK,
Donohue KG,
Danahy JF,
Badiavas E,
Falanga V
Publication year - 2003
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1046/j.1468-3083.2003.00575.x
Subject(s) - medicine , fluorouracil , dermatology , porokeratosis , keratosis , cancer
Topical 5‐fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5‐fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5‐fluorouracil used to manage a metastatic breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom